Global Cord Blood Registry 麻豆原创 Research Report 2024

Publication ID:

PB507249710

Publication Date:

July 9, 2024

Pages:

101

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Stem Cell Banking refers to the human stem cell transplantation for the purpose, with acquisition, processing, preservation and provides the ability to differentiate stem cell storage bank, has been called the "life bank".
The global Cord Blood Registry market was valued at US$ 1500 million in 2023 and is anticipated to reach US$ 2374.4 million by 2030, witnessing a CAGR of 6.8% during the forecast period 2024-2030.
The stem cell storage service market is primarily driven by the increasing recognition of stem cells' therapeutic potential and the growing demand for personalized and regenerative medicine. Stem cell storage services offer the option to collect and preserve stem cells from various sources, such as umbilical cord blood, adipose tissue, and dental pulp, for future medical use. The rising prevalence of chronic diseases and the need for novel treatments propel the adoption of stem cell storage, as these cells hold promise for regenerating damaged tissues and organs. However, the market also faces challenges, including ethical considerations related to the commercialization of stem cells and the lack of standardized guidelines for stem cell banking and storage. Ensuring the quality and viability of stored stem cells throughout the storage period is critical, and stringent regulatory oversight is required to address safety concerns and maintain public trust in stem cell storage services.
This report aims to provide a comprehensive presentation of the global market for Cord Blood Registry, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cord Blood Registry.
Report Scope
The Cord Blood Registry market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cord Blood Registry market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cord Blood Registry companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
CCBC
CBR
ViaCord
Esperite
Vcanbio
Boyalife
LifeCell
Crioestaminal
RMS Regrow
Cryo-cell
Cordlife Group
PBKM FamiCord
cells4life
Beikebiotech
StemCyte
Cellsafe Biotech Group
PacifiCord
Americord
Krio
Familycord
Cryo Stemcell
Stemade Biotech
Segment by Type
Umbilical Cord Blood Stem Cell
Embryonic Stem Cell
Adult Stem Cell
Other
Segment by Application
Diseases Therapy
Healthcare
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cord Blood Registry companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Cord Blood Registry 麻豆原创 Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Umbilical Cord Blood Stem Cell
1.2.3 Embryonic Stem Cell
1.2.4 Adult Stem Cell
1.2.5 Other
1.3 麻豆原创 by Application
1.3.1 Global Cord Blood Registry 麻豆原创 Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Diseases Therapy
1.3.3 Healthcare
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cord Blood Registry 麻豆原创 Perspective (2019-2030)
2.2 Cord Blood Registry Growth Trends by Region
2.2.1 Global Cord Blood Registry 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
2.2.2 Cord Blood Registry Historic 麻豆原创 Size by Region (2019-2024)
2.2.3 Cord Blood Registry Forecasted 麻豆原创 Size by Region (2025-2030)
2.3 Cord Blood Registry 麻豆原创 Dynamics
2.3.1 Cord Blood Registry Industry Trends
2.3.2 Cord Blood Registry 麻豆原创 Drivers
2.3.3 Cord Blood Registry 麻豆原创 Challenges
2.3.4 Cord Blood Registry 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cord Blood Registry Players by Revenue
3.1.1 Global Top Cord Blood Registry Players by Revenue (2019-2024)
3.1.2 Global Cord Blood Registry Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global Cord Blood Registry 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cord Blood Registry Revenue
3.4 Global Cord Blood Registry 麻豆原创 Concentration Ratio
3.4.1 Global Cord Blood Registry 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cord Blood Registry Revenue in 2023
3.5 Cord Blood Registry Key Players Head office and Area Served
3.6 Key Players Cord Blood Registry Product Solution and Service
3.7 Date of Enter into Cord Blood Registry 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Cord Blood Registry Breakdown Data by Type
4.1 Global Cord Blood Registry Historic 麻豆原创 Size by Type (2019-2024)
4.2 Global Cord Blood Registry Forecasted 麻豆原创 Size by Type (2025-2030)
5 Cord Blood Registry Breakdown Data by Application
5.1 Global Cord Blood Registry Historic 麻豆原创 Size by Application (2019-2024)
5.2 Global Cord Blood Registry Forecasted 麻豆原创 Size by Application (2025-2030)
6 North America
6.1 North America Cord Blood Registry 麻豆原创 Size (2019-2030)
6.2 North America Cord Blood Registry 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Cord Blood Registry 麻豆原创 Size by Country (2019-2024)
6.4 North America Cord Blood Registry 麻豆原创 Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cord Blood Registry 麻豆原创 Size (2019-2030)
7.2 Europe Cord Blood Registry 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Cord Blood Registry 麻豆原创 Size by Country (2019-2024)
7.4 Europe Cord Blood Registry 麻豆原创 Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cord Blood Registry 麻豆原创 Size (2019-2030)
8.2 Asia-Pacific Cord Blood Registry 麻豆原创 Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Cord Blood Registry 麻豆原创 Size by Region (2019-2024)
8.4 Asia-Pacific Cord Blood Registry 麻豆原创 Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cord Blood Registry 麻豆原创 Size (2019-2030)
9.2 Latin America Cord Blood Registry 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Cord Blood Registry 麻豆原创 Size by Country (2019-2024)
9.4 Latin America Cord Blood Registry 麻豆原创 Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cord Blood Registry 麻豆原创 Size (2019-2030)
10.2 Middle East & Africa Cord Blood Registry 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Cord Blood Registry 麻豆原创 Size by Country (2019-2024)
10.4 Middle East & Africa Cord Blood Registry 麻豆原创 Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 CCBC
11.1.1 CCBC Company Detail
11.1.2 CCBC Business Overview
11.1.3 CCBC Cord Blood Registry Introduction
11.1.4 CCBC Revenue in Cord Blood Registry Business (2019-2024)
11.1.5 CCBC Recent Development
11.2 CBR
11.2.1 CBR Company Detail
11.2.2 CBR Business Overview
11.2.3 CBR Cord Blood Registry Introduction
11.2.4 CBR Revenue in Cord Blood Registry Business (2019-2024)
11.2.5 CBR Recent Development
11.3 ViaCord
11.3.1 ViaCord Company Detail
11.3.2 ViaCord Business Overview
11.3.3 ViaCord Cord Blood Registry Introduction
11.3.4 ViaCord Revenue in Cord Blood Registry Business (2019-2024)
11.3.5 ViaCord Recent Development
11.4 Esperite
11.4.1 Esperite Company Detail
11.4.2 Esperite Business Overview
11.4.3 Esperite Cord Blood Registry Introduction
11.4.4 Esperite Revenue in Cord Blood Registry Business (2019-2024)
11.4.5 Esperite Recent Development
11.5 Vcanbio
11.5.1 Vcanbio Company Detail
11.5.2 Vcanbio Business Overview
11.5.3 Vcanbio Cord Blood Registry Introduction
11.5.4 Vcanbio Revenue in Cord Blood Registry Business (2019-2024)
11.5.5 Vcanbio Recent Development
11.6 Boyalife
11.6.1 Boyalife Company Detail
11.6.2 Boyalife Business Overview
11.6.3 Boyalife Cord Blood Registry Introduction
11.6.4 Boyalife Revenue in Cord Blood Registry Business (2019-2024)
11.6.5 Boyalife Recent Development
11.7 LifeCell
11.7.1 LifeCell Company Detail
11.7.2 LifeCell Business Overview
11.7.3 LifeCell Cord Blood Registry Introduction
11.7.4 LifeCell Revenue in Cord Blood Registry Business (2019-2024)
11.7.5 LifeCell Recent Development
11.8 Crioestaminal
11.8.1 Crioestaminal Company Detail
11.8.2 Crioestaminal Business Overview
11.8.3 Crioestaminal Cord Blood Registry Introduction
11.8.4 Crioestaminal Revenue in Cord Blood Registry Business (2019-2024)
11.8.5 Crioestaminal Recent Development
11.9 RMS Regrow
11.9.1 RMS Regrow Company Detail
11.9.2 RMS Regrow Business Overview
11.9.3 RMS Regrow Cord Blood Registry Introduction
11.9.4 RMS Regrow Revenue in Cord Blood Registry Business (2019-2024)
11.9.5 RMS Regrow Recent Development
11.10 Cryo-cell
11.10.1 Cryo-cell Company Detail
11.10.2 Cryo-cell Business Overview
11.10.3 Cryo-cell Cord Blood Registry Introduction
11.10.4 Cryo-cell Revenue in Cord Blood Registry Business (2019-2024)
11.10.5 Cryo-cell Recent Development
11.11 Cordlife Group
11.11.1 Cordlife Group Company Detail
11.11.2 Cordlife Group Business Overview
11.11.3 Cordlife Group Cord Blood Registry Introduction
11.11.4 Cordlife Group Revenue in Cord Blood Registry Business (2019-2024)
11.11.5 Cordlife Group Recent Development
11.12 PBKM FamiCord
11.12.1 PBKM FamiCord Company Detail
11.12.2 PBKM FamiCord Business Overview
11.12.3 PBKM FamiCord Cord Blood Registry Introduction
11.12.4 PBKM FamiCord Revenue in Cord Blood Registry Business (2019-2024)
11.12.5 PBKM FamiCord Recent Development
11.13 cells4life
11.13.1 cells4life Company Detail
11.13.2 cells4life Business Overview
11.13.3 cells4life Cord Blood Registry Introduction
11.13.4 cells4life Revenue in Cord Blood Registry Business (2019-2024)
11.13.5 cells4life Recent Development
11.14 Beikebiotech
11.14.1 Beikebiotech Company Detail
11.14.2 Beikebiotech Business Overview
11.14.3 Beikebiotech Cord Blood Registry Introduction
11.14.4 Beikebiotech Revenue in Cord Blood Registry Business (2019-2024)
11.14.5 Beikebiotech Recent Development
11.15 StemCyte
11.15.1 StemCyte Company Detail
11.15.2 StemCyte Business Overview
11.15.3 StemCyte Cord Blood Registry Introduction
11.15.4 StemCyte Revenue in Cord Blood Registry Business (2019-2024)
11.15.5 StemCyte Recent Development
11.16 Cellsafe Biotech Group
11.16.1 Cellsafe Biotech Group Company Detail
11.16.2 Cellsafe Biotech Group Business Overview
11.16.3 Cellsafe Biotech Group Cord Blood Registry Introduction
11.16.4 Cellsafe Biotech Group Revenue in Cord Blood Registry Business (2019-2024)
11.16.5 Cellsafe Biotech Group Recent Development
11.17 PacifiCord
11.17.1 PacifiCord Company Detail
11.17.2 PacifiCord Business Overview
11.17.3 PacifiCord Cord Blood Registry Introduction
11.17.4 PacifiCord Revenue in Cord Blood Registry Business (2019-2024)
11.17.5 PacifiCord Recent Development
11.18 Americord
11.18.1 Americord Company Detail
11.18.2 Americord Business Overview
11.18.3 Americord Cord Blood Registry Introduction
11.18.4 Americord Revenue in Cord Blood Registry Business (2019-2024)
11.18.5 Americord Recent Development
11.19 Krio
11.19.1 Krio Company Detail
11.19.2 Krio Business Overview
11.19.3 Krio Cord Blood Registry Introduction
11.19.4 Krio Revenue in Cord Blood Registry Business (2019-2024)
11.19.5 Krio Recent Development
11.20 Familycord
11.20.1 Familycord Company Detail
11.20.2 Familycord Business Overview
11.20.3 Familycord Cord Blood Registry Introduction
11.20.4 Familycord Revenue in Cord Blood Registry Business (2019-2024)
11.20.5 Familycord Recent Development
11.21 Cryo Stemcell
11.21.1 Cryo Stemcell Company Detail
11.21.2 Cryo Stemcell Business Overview
11.21.3 Cryo Stemcell Cord Blood Registry Introduction
11.21.4 Cryo Stemcell Revenue in Cord Blood Registry Business (2019-2024)
11.21.5 Cryo Stemcell Recent Development
11.22 Stemade Biotech
11.22.1 Stemade Biotech Company Detail
11.22.2 Stemade Biotech Business Overview
11.22.3 Stemade Biotech Cord Blood Registry Introduction
11.22.4 Stemade Biotech Revenue in Cord Blood Registry Business (2019-2024)
11.22.5 Stemade Biotech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

CCBC
CBR
ViaCord
Esperite
Vcanbio
Boyalife
LifeCell
Crioestaminal
RMS Regrow
Cryo-cell
Cordlife Group
PBKM FamiCord
cells4life
Beikebiotech
StemCyte
Cellsafe Biotech Group
PacifiCord
Americord
Krio
Familycord
Cryo Stemcell
Stemade Biotech

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.